[Hope Foundation](https://thehopefoundation.org)

Rolling (applications accepted during patient enrollment of SWOG trials)

Up to $75,000/year for 1–2 years (total cost, including up to 25% IDC)

Supports critical, non-standard components of SWOG cancer clinical trials to prevent activation delays and enable essential data collection.

Only funds components not supported by other sources; PI/Co-PI salary not allowed.

--- ## Description The SWOG Trial Support (STrS) program, administered by The Hope Foundation in partnership with SWOG, provides peer-reviewed funding for essential, non-standard components of cancer clinical trials during patient enrollment. Its goal is to prevent delays in trial activation and ensure the collection of critical data by supporting needs such as atypical tissue or data collection, provision of materials to trial sites, and patient-reported outcomes. STrS primarily funds core trial components and biomarker-related work not covered by other sources, with a focus on projects likely to inform future SWOG protocols and improve patient outcomes. --- ## Due Dates - Applications are accepted on a rolling basis during the patient enrollment period of eligible SWOG clinical trials. --- ## Funding Amount - Awards are up to $75,000 per year, for 1 or 2 years (total cost, including indirect costs). - Indirect costs (IDC) are limited to 25%. --- ## Eligibility - Only components of approved and activated SWOG cancer clinical trials are eligible. - The applicant must be the Principal Investigator (PI) of the SWOG trial. - The funding request must be reviewed and approved by the relevant SWOG Committee Chair and Executive Officer before submission. - STrS does **not** fund PI or Co-PI salary support. - STrS is intended for non-standard trial components not supported by other sources (e.g., industry, R01, BIQSFP). No overlap with other funding is allowed. - Integrated biomarker requests must have been previously denied BIQSFP funding and be highly likely to inform future SWOG protocols. --- ## Application Process - Submissions are expected at the time of SWOG clinical trial capsule submission for Executive Review, but can also be considered during patient enrollment if new needs arise. - The application requires: - Completed STrS application form (3 pages) - Budget and justification (using the [Hope Foundation budget template](https://thehopefoundation.org/wp-content/uploads/2024/12/Budget-Template-Hope-Fdn.xlsx)) - The application is reviewed alongside the trial's Executive Review and translational medicine assessments. - Funding decisions are based on the impact and significance of the proposed STrS component. - Notification of award typically coincides with Executive Review approval; unexpended funds at year-end may support previously unfunded, reviewed applications. --- ## Additional Information - STrS funds are reallocated if overlapping external funding is secured after award. - The program does not support standard trial components or those already funded by SWOG, NIH, or industry. - Upon request, The Hope Foundation can provide a letter of financial support for NCTN Steering Committee submissions. --- ## External Links - [Program Details & Application Form](https://thehopefoundation.org/funding-opportunities/swog-trial-support-strs) - [STrS Application Guide (PDF)](https://thehopefoundation.org/wp-content/uploads/2022/07/STrS-Application-7.8.22.pdf) - [Hope Foundation Budget Template (XLSX)](https://thehopefoundation.org/wp-content/uploads/2024/12/Budget-Template-Hope-Fdn.xlsx) - [Hope Foundation Funding Opportunities](https://thehopefoundation.org/funding-opportunities/) --- ## Contact Information | Contact Type | Details | |---------------------|-------------------------------------------------------------------------| | Foundation Address | 24 Frank Lloyd Wright Drive, P.O. Box 483 (Suite 4300K), Ann Arbor, MI 48105 | | Phone | (734) 492-0277 | | Contact Form | [Hope Foundation Contact Page](https://thehopefoundation.org/contact/) |

SWOG Trial Support (STrS)

Sign in to see full grant listing